Abstract 2944: Synergistic lethality of combination treatment with Trop2-directed antibody-drug conjugate (IMMU-132) and Apo2L/TRAIL in triple negative breast cancer (TNBC)
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Yonit A. Addissie, Manari Kundu, Yoshimi E. Greer, Stanley Lipkowitz
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409633624